BackKeros Therapeutics Overview

Keros Therapeutics Goodwill

Keros Therapeutics's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average

Loading

Keros Therapeutics Goodwill History

Loading

Keros Therapeutics vs. peers: Goodwill Comparison

Loading

Keros Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Keros Therapeutics (KROS) FAQ

Keros Therapeutics (KROS) currently reports a goodwill of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Keros Therapeutics's goodwill history and peer comparisons.

Keros Therapeutics's goodwill changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Keros Therapeutics reported $0 in goodwill as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Keros Therapeutics, and consider following KROS for alerts when major investors trade the stock.

Keros Therapeutics is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KROS with unrelated industries.